Lactate can substitute for glucose as a metabolic substrate. We report a patient with acute liver failure who was awake despite a glucose level of 0.7 mmol/l with very high lactate level of 25 mmol/l. The hypoglycaemia+hyperlactataemia combination may be considered paradoxical since glucose is the main precursor of lactate and lactate is reconverted into glucose by the Cori cycle. Literature relevant to the under-lying mechanism of combined deep hypoglycaemia and severe hyperlactataemia was assessed. We also assessed the literature for evidence of protection against deep hypoglycaemia by hyperlactataemia. Four syndromes demonstrating hypoglycaemia+hyperlactataemia were found: 1) paracetamol-induced acute liver failure, 2) severe malaria, 3) lymphoma and 4) glucose-6-phosphatase deficiency. An impaired Cori cycle is a key component in all of these metabolic states. Apparently the liver, after exhausting its glycogen stores, loses the gluconeogenic pathway to generate glucose and thereby its ability to remove lactate as well. Several patients with lactic acidosis and glucose levels below 1.7 mmol/l who were not in a coma have been reported. These observations and other data coherently indicate that lactate-protected hypoglycaemia is, at least transiently, a viable state under experimental and clinical conditions. Severe hypoglycaemia+hyperlactataemia reflects failure of the gluconeogenic pathway of lactate metabolism. The existence of lactate-protected hypoglycaemia implies that patients who present with this metabolic state should not automatically be considered to have sustained irreversible brain damage. Moreover, therapies that aim to achieve hypoglycaemia might be feasible with concomitant hyperlactataemia.
A 55-year-old man presented to the emergency department because he felt increasingly ill after ingesting 100 g (200 tablets) of paracetamol two days earlier. Physical examination showed an awake patient with a Glascow Coma Scale score of 15. He was icteric without signs of chronic liver disease and had a temperature of 34.1°C. Blood tests showed the following results: paracetamol 490 μmol/l, glucose 0.7 mmol/l, lactate 25 mmol/l, arterial pH 7.05, HCO 3 -4 mmol/l, base excess -25 mmol/l, aspartate aminotransferase 3976 U/l, lactate dehydrogenase 2016 U/l, ammonia 178 μmol/l, platelet count 14x10 9 /l and an International Normalized Ratio of 2.9. Because of acute liver failure a liver transplantation was performed. Five years after transplantation, the patient had no neurological abnormalities and normal liver function. The patient provided written informed consent for the publi-cation of these data in accordance with guidelines of our Institutional Review Board.
Hyperlactataemia
Lactate can only be produced and removed by the enzyme lactate dehydrogenase through interconversion with pyruvate. Subsequently, pyruvate can be oxidised in mitochondria or can be converted into glucose or glycogen via gluconeogenesis. Mitochondria can fully oxidise lactate, with an adenosine triphosphate-yield nearly the same as that of glucose 1 . During critical disease, hyperlactataemia (>2.0 mmol/l) occurs because of several factors, including increased production and decreased clearance by many tissues, in particular the liver and kidneys. A key factor that directly causes increased lactate production is increased ß 2 -adrenergic stress, irrespective of tissue oxygen status 3, 4 . The magnitude of hyperlactataemia is arguably the strongest single biochemical indicator of an adverse outcome in critically ill patients 3 . Particularly when hepatic lactate clearance is impaired, levels >15 mmol/l can occur 5 .
Hypoglycaemia+hyperlactataemia
Under physiological conditions, peripherally produced lactate is converted to glucose by hepatic gluconeogenesis (the Cori cycle, Figure 1 ).
The most remarkable aspect of this case was that the patient was conscious despite a glucose level of only 0.7 mmol/l, for which coma would have been expected.
DISCUSSION

Hypoglycaemia
When glucose levels decrease, several stress responses occur to preserve the normoglycaemic state, including decreased insulin secretion and adrenergic stimulation 1,2 , resulting in glycogenolysis and gluconeogenesis. Hepatic glycogenolysis is of limited utility since liver glycogen is depleted within two days of starvation 1 , which frequently occurs in seriously ill patients. In the presented case, liver glycogen stores were probably exhausted and glucose levels could only be maintained by hepatic glucose production through gluconeogenesis from precursors such as amino acids, glycerol and lactate ( Figure 1 ). Hypoglycaemia occurs when gluconeogenesis fails to equal glucose demand. Neuroglycopenic symptoms become manifest at glucose levels <2.8 mmol/l, and coma generally occurs at levels <1.7 mmol/l with neuronal death ensuing at levels <1.0 mmol/l 2 . Figure 1 : Exchange of glucose and lactate. The liver and muscle are major sites of glycogen storage. Muscle can take up glucose from the circulation, but cannot release it so muscle glycogen cannot contribute to glucose levels. However, muscle tissue can release lactate and amino acids into the circulation and all respiring tissues can take up lactate. Once liver glycogen stores are depleted, blood glucose depends on gluconeogenesis. The hepatic conversion of circulating lactate into glucose and its release into the circulation is called the Cori cycle.
The key acquired deficiency of the Cori cycle that is relevant for the hypoglycaemia+hyperlactataemia combination is failure of the liver to convert pyruvate into glucose (see asterisk). LDH=lactate dehydrogenase.
During certain pathophysiological conditions, hypoglycaemia and hyperlactataemia can apparently coexist. This may seem paradoxical since lactate is an important source of glucose and vice versa. This raises two related questions. What is the source of the elevated lactate levels and why is glucose not produced from lactate? Since hypoglycaemia is a strong stimulant of gluconeogenesis and lactate is an important gluconeogenic precursor, there must be some dysfunction of the Cori cycle.
To investigate if hypoglycaemia and hyperlactataemia coexist in various diseases, we searched the literature for patients displaying hyperlactataemia with concomitant hypoglycaemia (Figure 2 ). This state was identified in at least four acute conditions: a) paracetamol intoxication, b) lymphoma/leuk-aemia, c) severe malaria, and d) glucose-6-phosphatase deficiency, an inborn error of metabolism. a) Severe acetaminophen intoxication can lead to acute liver failure within 48 hours and hyperlactataemia >3.5 mmol/l typically identifies patients who require liver transplantation for survival 6 . As observed for other aetiologies, the subsequent onset of severe hypoglycaemia heralds progressive hepatic failure 5 . b) Lymphoma and leukaemia are occasionally associated with hyperlactataemia with concomitant hypoglycaemia. This state generally reflects advanced disease and a dismal haematologic prognosis [7] [8] [9] . A deficiency of the hepatic gluconeogenic enzyme glucose-6-phosphatase was demonstrated in children who died from acute lymphatic leukaemia 10 . c) Severe malaria can present with a combination of hypoglycaemia and lactic acidosis and both abnormalities predict a poor outcome 11, 12 . Elevated circulating lactate and alanine levels in hypoglycaemic patients indicate impaired gluconeogenesis 13 . Reduced hepatic perfusion due to microvascular obstruction is the presumed mechanism of impaired gluconeogenesis. d) Glucose-6-phosphatase deficiency (von Gierke disease, glycogen storage disease type I) is an inherited metabolic disease characterised by growth retardation and hepatic enlargement from glycogen accumulation. It can be caused by several defects in the pathway from intracellular glucose-6-phosphate to extracellular glucose. Defining signs of this syndrome are fasting hypoglycaemia and hyperlactataemia 14 . Glucose-6-phosphate is generated from stored glycogen but cannot be converted into glucose and exported to the blood stream. Through glycolysis, glucose-6-phosphate is converted to lactate, which then exits the liver 1 (Figure 1 ). Protection during hypoglycaemia+hyperlactataemia Experiments in vivo have shown that neurons readily oxidise lactate and may even prefer lactate to glucose as an energy source 15 . Lactate protects brain function during hypoglycaemia in healthy subjects 16 . In several reported cases lactate apparently protected against the deleterious effects of hypoglycaemia (black symbols in Figure 2 ). a) For paracetamol intoxication we found another reported case 17 with deep hypoglycaemia (<1 mmol/l) and hyperlactataemia (16.4 mmol/l) with a near-maximal Glascow Coma Scale score of 14. b) Lymphoma with hypoglycaemia+hyperlactataemia has been described in an awake Angus cow 18 , and also in three conscious patients 7, 19, 20 . In one of these cases positron emission tomography demonstrated that cerebral glucose uptake was virtually absent in a conscious patient 7 . c) For severe malaria, we found patients who were not in a coma with glucose levels as low as 0.2 mmol/l and lactate levels as high as 22.5 mmol/l 11, 13 . d) In children with glucose-6-phosphatase deficiency it has long been recognised that elevated lactate levels can protect against the neurological symptoms of hypoglycaemia. Children or adults who present with hypoglycaemia+hyperlactataemia should have inborn metabolic diseases considered. These include some organic acidaemias and mitochondrial disorders. However, we could only find evidence for cerebral protection at higher lactate levels (i.e. 8 mmol/l 14, 21 ) resulting from the apparent use of lactate as a cerebral fuel in patients with glucose-6phosphatase deficiency. Irrespective of potential cerebral protection of hyperlactataemia against hypoglycaemia it is obvious that the overall prognosis is usually quite poor if liver failure is the underlying cause of this metabolic state 6 . Figure 3 depicts the subsequent stages with respect to glycogen, glucose and lactate when a patient progresses from the normal well-fed condition to complete hepatic failure.
Mechanism of hypoglycaemia+hyperlactataemia
In all cases with hypoglycaemia and hyperlactataemia, deficient gluconeogenesis in the Cori cycle must be present. The precise mechanism underlying this impaired gluconeogenesis has not been fully elucidated. But as patients with inherited glucose-6-phosphatase deficiency demonstrate, acquired impairment of glucose-6-phosphatase may be relevant in liver failure due to intoxication, lymphoma or malaria. In general, impaired mitochondrial function will inhibit lactate dehydrogenase and the tricarboxylic acid cycle through reduced oxidation of nicotinamide adenine dinucleotide to nicotinamide adenine dinucleotide (reduced) 1 . Multiple causes for impaired hepatic mitochondrial function are relevant including capillary obstruction in malaria or direct disruption of the tricarboxylic acid cycle in paracetamol intoxication.
Many tissues can convert lactate into glucose-6phosphate but only the liver and kidneys can export glucose into the circulation 1 . Very low glucose levels thus indicate that these organs have lost the ability to generate sufficient glucose through gluconeogenesis.
The apparent paradox that high lactate levels coexist with very low circulating levels of glucose, its usual precursor, can only be explained by assuming that lactate is produced either through glycogenolysis in tissues other than liver (e.g. muscle) or from circulating precursors other than glucose. Since the supply of glycogen is limited and proteolysis is known to predominate in critical disease, amino acids resulting from proteolysis 1 will become the main source of lactate as disease progresses and the liver becomes a lactate producer instead of a lactate consumer.
The extreme metabolic combination of hypoglycaemia and hyperlactataemia does not automatically lead to coma because lactate can serve as an alternative fuel for the brain. Glucose was considered to be an obligate acute fuel for the brain 2 since other substances that serve as fuel, such as fatty acids and amino acids, cannot substitute for glucose when deep hypoglycaemia occurs acutely, nor are ketones available in the acute situation. Lactate has clearly emerged as the major exception to this wellestablished rule 7, 16 . The modern perspective on lactate in metabolism provides a very plausible explanation for lactate-protection. Far from being a 'waste product', lactate is metabolised by almost all tissues, including the brain, kidneys, heart, liver and skeletal muscle 22 . Recent studies even indicate that lactate is the prime fuel used by neurons 15 .
CONCLUSION
In conclusion, high lactate levels can provide protection during hypoglycaemic episodes. This unique role of lactate may be of more than mere theoretical importance, as it may be applied for specific therapeutic interventions. The purposeful induction of hypoglycaemia with concomitant hyperlactataemia may be useful to combat infectious agents that are dependent on glycolysis or treat advanced tumours that are usually strongly glucose-dependent, as a result of the so-called Warburg effect 23, 24 .
